Vice President of Liver Disease at InSphero, Francisco Verdeguer, presents new data on the application of 3D in vitro preclinical models for drug discovery in MASH, with a focus on verifying novel anti-fibrotic candidates.
- Webinar
3D In Vitro Preclinical Models for Drug Discovery in MASH: Validation of Novel Anti-Fibrotics
- Liver Disease